6/16/17 CURRICULUM VITAE JOEL W. HAY, PhD PERSONAL INFORMATION Business/Mail Address Professor of Pharmaceutical Economics and Policy & Professor of Health Policy and Economics University of Southern California Schaeffer Center for Health Policy and Economics University Park Campus, Verna & Peter Dauterive Hall (VPD 214-L) 635 Downey Way Los Angeles, CA 90089-3333 USA Business Telephone Office: (818) 338-5433 Assistant: (213) 821-7940 Fax: (213) 740-3460 (ATTN: Joel Hay) E-Mail [email protected] USC Websites : http://healthpolicy.usc.edu/ListItem.aspx?ID=4 http://pharmacyschool.usc.edu/faculty/profile/?id=374 Graduate Program Website : http://pharmacyschool.usc.edu/programs/pep/ Schaeffer Center Street Address 635 Downey Way Los Angeles, CA 90089-3333 USA (Deliveries, e.g. Fedex, UPS) Main Phone/Front Desk: (213) 821-7940 J Hay Office: (213) 821-8160 Fax: (213) 740-3460 (ATTN: Samantha) http://healthpolicy.usc.edu Contact Information for Non-USC Activities Joel W. Hay, PhD 22101 Dardenne St. Calabasas, CA 91302 818-338-5433 [email protected] Joel W. Hay, Ph.D. -- C.V. -2- 6/16/17 EDUCATION 1974 B.A. (Summa cum laude), Economics, Amherst College 1975 M.A., Economics, Yale University 1976 M.Phil., Economics, Yale University 1980 Ph.D., Economics, Yale University PROFESSIONAL EXPERIENCE March 2009 – Present Full Professor (with tenure), Pharmaceutical Economics and Policy; School of Pharmacy Professor (by courtesy), Department of Economics; University of Southern California, Los Angeles, California. September 2009-Present Full Professor, Health Economics and Policy Leonard D. Schaeffer Center for Health Policy and Economics University of Southern California, Los Angeles, California 1992 – 2009 Associate Professor (with tenure), Pharmaceutical Economics and Policy; School of Pharmacy. Associate Professor (by courtesy), Department of Economics; University of Southern California, Los Angeles, California. September 1985 - May 1992 Senior Research Fellow, Hoover Institution, Stanford University, Stanford, California. July 1983 - September 1985 Senior Policy Analyst, Project HOPE, Center for Health Affairs, Millwood, Virginia. January 1981 - June 1983 Visiting Lecturer, M.P.H. Program, Yale University, Department of Epidemiology and Public Health, and Institution for Social and Policy Studies. June 1980 - September 1984 Assistant Professor, Department of Behavioral Sciences and Community Health, School of Dental Medicine University Connecticut Health Center, Farmington, Connecticut. (from 9/81) Assistant Professor, Department of Economics, UConn Storrs. University of Connecticut Graduate School, Storrs, Connecticut. June 1978 - June 1980 Assistant Research Professor, Human Resources Research Center, University of Southern California, Los Angeles, California. ADDITIONAL EXPERIENCE: 2016-2017 Conference Co-Chair and Planning Committee, International Academy of Health Preference Research, North American Conference, Boston MA, June 2017. 2016 Invited Forum Participant, AMCP Partnership Forum: FDAMA Section 114—Improving the Exchange of Health Care Economic Data, Academy of Managed Care Pharmacy. 2016-present Voting Member, Cochrane Collaboration, www.chochrane.org. 2015 External Reviewer, Italian Ministry of Health, General Direction for Scientific Research and Health Innovation. 2015 Invited Advisor, U.S. Food and Drug Administration Policy on Review of Health Economics Modeling Claims (FDAMA Section 114). 2014-present Founding Member, International Academy of Health Preference Research (iahpr.org). 2013-2015 Extramural Reviewer, Healthcare Systems & Value Research Study Section Review Panel, Agency for Healthcare Research & Quality (AHRQ), U.S. Dept. of Health & Human Services. Joel W. Hay, Ph.D. -- C.V. -3- 6/16/17 2012 External Reviewer, Cochrane Tobacco Addiction Research Group, Cochrane Collaboration, www.cochrane.org. 2012 Health Economics Expert Consultant, State Attorneys General Working Group on Pharmaceutical Benefits Management (PBM) Market Competition Issues. 2011-2013 Extramural Reviewer, Healthcare Systems & Value Research Study Section Review Panel, Agency for Healthcare Research & Quality (AHRQ), U.S. Dept. of Health & Human Services. 2011 Extramural Grant Reviewer, Health Services Research Study Section, Agency for Healthcare Research & Quality (AHRQ), U.S. Dept. of Health & Human Services. 2010 Extramural Grant Reviewer, Health Services Research Study Section, Agency for Healthcare Research & Quality (AHRQ), U.S. Dept. of Health & Human Services. 2010 External Grant Reviewer, Netherlands Organisation for Health Research and Development (ZonMw) Health Technology Assessment Methodology Programme. 2010 External Program Contract Reviewer, Agency for Healthcare Research & Quality (AHRQ), U.S. Dept. of Health & Human Services; Developing Evidence to Inform Decisions about Effectiveness-2: The DEcIDE-2 Network. 2007-2013 Leadership Group, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Disease Management and Prevention Task Force. 2007-2009 Leadership Group, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Patient Preferences Research Task Force. 2006-2010 Co-Chair, ISPOR Drug Cost Task Force. 2006 Chair, Awards Committee; “The 2006 ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award.” Presented to Prof. George Torrance at the 11’th Annual International Meeting, Philadelphia, PA. 2005 External Project Reviewer; “The Uninsured and Access to Prescription Drugs in California. The Petris Center on Health Care Markets & Consumer Welfare, University of California, Berkeley. 2005 External Program Reviewer, Agency for Healthcare Research & Quality, Dept. of Health & Human Services; Developing Evidence to Inform Decisions about Effectiveness: The DEcIDE Network. 2004-2010 Health Policy Scientific Council, Intl. Soc. for Pharmacoeconomics & Outcomes Research. 2004-2014 Elected Executive Board Member, American Society of Health Economists (Ashecon.org). 2004-2010 Scientific Advisory Board Member, Disease Management Association of America 2002-2003 Institute of Medicine, National Academy of Sciences. Commissioned Author “Vaccine Reimbursement Policy in the US.” 2001-Present Health Economist, UCLA Center for Vaccine Research, UCLA Harbor Medical Center, Torrance, CA. 2001 Health Plan Reform Consultant, Hong Kong Hospital Authority, Hong Kong. 2000 External Reviewer, National Institute on Aging, NIH Small Grants Program. 1999 External Reviewer, National Institutes of Health, National Institute on Aging, 1999-2011 Co-Investigator, USC Alzheimer Research Centers of California Research Program, California Dept. of Health Services. 1999 Consultant, Univ. Michigan Survey Research Center ADAMS/HRS Dementia Project 1999 External Reviewer, National Insts. of Health, National Institute of Digestive Diseases and Nutrition, Division of Digestive Diseases and Nutrition Hepatitis C Antiviral Long-term Therapy to Prevent Cirrhosis (HALT-C) Ancillary Studies Committee. 1999-2000 Economics Research Consultant, U.S. AHRQ, Southern California Evidence-Based Medicine Practice Project: Deep Vein Thrombosis Treatment in Trauma Surgery Literature Synthesis and Guideline Development. 1999 Member, Long Range Steering Committee Task Force, Harbor-UCLA Medical Center Research and Education Institution, Torrance, CA. 1998-2011 Rand USC Project Coordinator, U.S. Agency for Health Research and Quality, Southern California Evidence-Based Medicine Practice Project. 1998-2002 Founding Editor-In-Chief, Value in Health, Journal of the International Society for Pharmacoeconomics and Outcomes Research. 1998 External Reviewer, Cal Dept of Health Services Alzheimer’s Program Research Fund. 1998-2008 Member, Pharmacy Practice Research Roundtable. 1998-2007 Member, Intl. Working Group on Alzheimer Disease Pharmacoeconomics Research. Joel W. Hay, Ph.D. -- C.V. -4- 6/16/17 1998-2006 Member, Coronary Heart Disease: The Interdisciplinary Council on Reducing the Risk, co- sponsored by the American Heart Association & Bristol-Myers Squibb. Dallas, TX. 1997-98 Co-Chair: ISPOR Working Group on Guidelines for Pharmacoeconomic Research. 1997-98 External Reviewer. Asset and Health Dynamics among the Oldest Old- Dementia Survey Supplement. University of Michigan Inst. for Social Research, Ann Arbor, MI. 1997 – Present Economic Consultant, Rand Corporation, Health Outcome Research Group, Santa Monica, CA 1996-1998 Co-Chair and Primary Organizer: ISPOR Lipid Pharmacoeconomics Conference. Orlando, FL. 1996-1998 Elected Member, Board of Directors, and Founding Member, International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Philadelphia, PA. 1995-2000 Member, Expert Advisory Panel on Drug Utilization Review, United States Pharmacopoeial Convention, Rockville, MD. 1995-96 Research & Graduate Affairs Cmte., American Assoc. Colleges of Pharmacy, Alexandria, VA. 1994-95 Technical Review Study Section, "HIV Costs and Services Utilization Study (HCSUS)," Agency for Health Care Policy & Research, US Dept. Health & Human Serv., Rockville, MD. 1993-94 Member, Research Advisory Panel for Outcome Studies, Wellpoint Pharmacy Management, Blue Cross of Southern California. 1993-1998 Member, Advis. Cmte., American Soc. Consultant Pharmacists Research Foundation 1993 Member, Planning Committee, American Society of Consultant Pharmacists for ASCP Foundation Pharmacoeconomics Fellowship in Geriatric Long-Term Care 1992-1993 Technical Review Panelist, Drug Utilization Review Demonstration Project Contracts, Health Care Financing